• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Saba Capital Management, L.P. sold $16,112,220 worth of shares (1,608,006 units at $10.02)

    11/1/22 12:55:51 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials
    Get the next $RACB alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Saba Capital Management, L.P.

    (Last) (First) (Middle)
    405 LEXINGTON AVENUE
    58TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Research Alliance Corp. II [ RACB ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    10/31/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 10/31/2022 S 1,608,006 D $10.02 301,578 I -
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    Saba Capital Management, L.P.

    (Last) (First) (Middle)
    405 LEXINGTON AVENUE
    58TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Weinstein Boaz

    (Last) (First) (Middle)
    405 LEXINGTON AVENUE
    58TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    Explanation of Responses:
    William Manzolillo 11/01/2022
    Boaz Weinstein 11/01/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RACB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RACB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Saba Capital Management, L.P. sold $16,112,220 worth of shares (1,608,006 units at $10.02)

    4 - Research Alliance Corp. II (0001819724) (Issuer)

    11/1/22 12:55:51 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    SEC Form 4: Saba Capital Management, L.P. sold $401,702 worth of shares (40,990 units at $9.80)

    4 - Research Alliance Corp. II (0001819724) (Issuer)

    6/29/22 9:29:54 AM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    SEC Form 3: New insider Saba Capital Management, L.P. claimed ownership of 1,950,574 shares

    3 - Research Alliance Corp. II (0001819724) (Issuer)

    6/15/22 12:39:19 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    $RACB
    SEC Filings

    View All

    SEC Form 15-12G filed by Research Alliance Corp. II

    15-12G - Research Alliance Corp. II (0001819724) (Filer)

    12/16/22 4:05:24 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    SEC Form 25-NSE filed by Research Alliance Corp. II

    25-NSE - Research Alliance Corp. II (0001819724) (Subject)

    12/6/22 4:50:13 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    Research Alliance Corp. II filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Research Alliance Corp. II (0001819724) (Filer)

    12/6/22 4:30:44 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    $RACB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Research Alliance Corp. II Will Redeem Public Shares

    Research Alliance Corp. II (the "Company") (NASDAQ:RACB), a special purpose acquisition company, today announced that, the Company will redeem all of its outstanding shares of Class A Common Stock, par value $0.0001, issued by the Company in its initial public offering (the "Public Shares"), effective as of the close of business on December 2, 2022, if at the Company's Special Meeting on December 2, 2022 the requisite stockholders of the Company approve (the "Stockholder Approval") the proposed amendment to the Company's Amended and Restated Certificate of Incorporation (the "Charter Amendment") and the proposed amendment to that certain Investment Management Trust Agreement, dated March 17

    11/28/22 5:16:00 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility

    Globally focused radiopharmaceutical company achieves significant milestone to accelerate the operationalization of their 80,000 sq ft radioligand manufacturing facility POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announced today that the U.S. Nuclear Regulatory Commission (NRC) has issued a Materials License for its new production facility located in Indianapolis, Indiana. POINT is currently finishing renovations to its 80,000-square-foot radiopharmaceutical manufacturing center which, when complete, will make it one of the largest, state-of-the-art, Good Manufacturing Practices (

    4/28/21 9:07:00 AM ET
    $RACB
    $RACA
    Consumer Electronics/Appliances
    Industrials
    Business Services
    Finance

    Research Alliance Corp. II, Sponsored by RA Capital Management, L.P., Announces Closing of $149.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option to Purchase Additional Shares

    LAS VEGAS--(BUSINESS WIRE)--Research Alliance Corp. II (Nasdaq:RACB) (the “Company”) announced today that on March 22, 2021 it closed its initial public offering of 14,950,000 shares of Class A common stock, including 1,950,000 shares issued pursuant to the exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per share, resulting in gross proceeds of $149,500,000. The Company, sponsored by RA Capital Management, L.P., is led by Chairman and CEO Peter Kolchinsky PhD, CIO Matthew Hammond, PhD and CFO Tess Cameron. The Company is a blank check company formed for the purpose of effecting a business combination with one or more businesses in the

    3/22/21 2:30:00 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    $RACB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Research Alliance Corp. II (Amendment)

    SC 13G/A - Research Alliance Corp. II (0001819724) (Subject)

    2/14/23 2:39:02 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Research Alliance Corp. II (Amendment)

    SC 13G/A - Research Alliance Corp. II (0001819724) (Subject)

    2/14/23 2:18:09 PM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Research Alliance Corp. II (Amendment)

    SC 13G/A - Research Alliance Corp. II (0001819724) (Subject)

    2/14/23 7:41:31 AM ET
    $RACB
    Consumer Electronics/Appliances
    Industrials